Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program... Show more
HUM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 49 cases where HUM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where HUM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The 50-day moving average for HUM moved above the 200-day moving average on September 08, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HUM advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 210 cases where HUM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for HUM moved out of overbought territory on September 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on September 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HUM as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for HUM turned negative on September 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.823) is normal, around the industry mean (4.092). P/E Ratio (21.183) is within average values for comparable stocks, (17.152). Projected Growth (PEG Ratio) (1.073) is also within normal values, averaging (0.893). HUM has a moderately low Dividend Yield (0.013) as compared to the industry average of (0.023). P/S Ratio (0.271) is also within normal values, averaging (0.662).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HUM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HUM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
a company offers health insurance coverage and related services
Industry PublishingBooksMagazines
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UCC | 53.43 | 0.55 | +1.04% |
ProShares Ultra Consumer Discretionary | |||
KLIP | 33.14 | 0.03 | +0.09% |
KraneShares KWEB Covered Call Strat ETF | |||
CPSR | 24.74 | N/A | -0.01% |
Calamos S&P 500 Structured Alt Protection ETF - March | |||
IFRA | 52.01 | -0.33 | -0.63% |
iShares US Infrastructure ETF | |||
KBWD | 14.11 | -0.10 | -0.70% |
Invesco KBW High Dividend Yld Fincl ETF |
A.I.dvisor indicates that over the last year, HUM has been loosely correlated with CVS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HUM jumps, then CVS could also see price increases.
Ticker / NAME | Correlation To HUM | 1D Price Change % |
---|---|---|
HUM | 100% | -0.82% |
Publishing: Books/Magazines industry (14 stocks) | 65% Loosely correlated | -1.48% |
Consumer Services industry (456 stocks) | 29% Poorly correlated | +0.50% |